facebook pixel
chevron_right Health
Little change in proportion of U.S. kids with autism
After steadily climbing for two decades, the proportion of US children with autism may be leveling off, a recent study suggests. As of 2016, approximately 2.8 percent of US children from 3 to 17 years old had autism spectrum disorders (ASD), researchers report in JAMA. At this time, it is not safe to conclude firmly that autism rates are no longer rising, Bao added. Behavioral, educational, speech and language therapy may help reduce the severity of autism symptoms in some children.
Vermont becomes ninth U.S. state to legalize marijuana
Vermont became the ninth US state and third in the Northeast to legalize recreational marijuana use on Monday when Republican Governor Phil Scott signed a bill passed by the legislature earlier this month. Neighboring Massachusetts, nearby Maine and six other states have legalized marijuana use as a result of voter initiatives. New Hampshire's House of Representatives on Tuesday passed a similar bill to legalize recreational marijuana use.
Body broker who sold diseased remains is convicted of fraud
A Detroit businessman who sold and leased donated body parts for two decades was convicted Monday of defrauding medical customers by selling them diseased human remains. Federal agents found a grisly scene when they raided Rathburn's warehouse in 2013, including remains frozen together flesh on flesh. The buying and selling of body parts for research and education - Rathburn's line of business - is legal under US law.
'Misperceptions' keep some from agreeing to donate organs after death
In particular, survey respondents reported concerns about receiving adequate medical care if they registered to donate organs after they died. Nearly 85 percent of respondents were willing to donate organs after they died, which didn't differ much by age, gender, religion or location. Willingness to donate a family member's organs depended on whether families had talked about it before. The transplant team is only called in when patients meet the criteria for brain death or unrecoverable injuries, Florman said.
Hospital patients less likely to survive 'off-hours' cardiac arrest
Researchers examined data on more than 151,000 adults who had a cardiac arrest at 470 US hospitals between 2000 and 2014. These events are often fatal, although survival odds are typically much better when a cardiac arrest happens inside a hospital than when it occurs elsewhere. In the current study, roughly 79,000 patients, or 52 percent, had a cardiac arrest during off-hours in the hospital.
Why regular coffee intake could worsen sports performance
Just as most of us embrace the caffeine kick from our morning cup of joe, athletes often turn to caffeine to boost their sports performance. It may also benefit exercise performance; research has shown that it can improve endurance and increase muscular strength. The daily caffeine intake of each participant was also noted, and the researchers looked at whether this impacted their performance outcomes on the sprint tests.
Fournier's gangrene: What it is, causes, symptoms, and treatment
Fournier's gangrene is a sometimes life-threatening form of necrotizing fasciitis that affects the genital, perineal, or perianal regions of the body. The symptoms of Fournier's gangrene often begin with a general feeling of being unwell. The presence of Fournier's gangrene can set off a cascade of symptoms that can ultimately be deadly. A diagnosis of Fournier's gangrene may be made after taking a medical history and assessing symptoms.
'Just breathing' is enough to spread flu
Researchers say that simply breathing out is enough to spread the flu virus. The common belief is that flu is spread through coughs and sneezes from infected individuals and from touching surfaces contaminated with the virus. The new study reveals that people with the flu can shed the infectious virus into the air around them just by breathing.
What to know about a black line on the nail
Fast facts on black lines on the nails: There are many causes of this condition, both of no concern and serious. More seriously, a black line or lines on the nails can indicate the presence of melanoma, a dangerous form of skin cancer. There are times when a person may experience black lines on the nail. Splinter hemorrhages appear as small black or deep-red lines and are caused by injuries to the small blood vessels under the nail beds.
Kentucky accuses McKesson of helping fuel opioid epidemic
Kentucky's attorney general on Monday accused the drug distributor McKesson Corp of helping fuel the opioid epidemic by failing to halt shipments of suspiciously large or frequent orders by pharmacies of prescription painkillers. The complaint by Kentucky Attorney General Andy Beshear was filed in a state court and came amid a flurry of lawsuits by states and local governments against opioid manufacturers and distributors seeking to hold them accountable for the epidemic.
Celgene to buy Juno for $9 billion to boost cancer pipeline
Celgene Corp will pay $9 billion in cash to buy experimental cancer drugmaker Juno Therapeutics Inc, bulking up its developmental pipeline as it works to reduce reliance on its own cancer treatment Revlimid. Celgene said on Monday it would pay $87 per share for the roughly 90 percent of Juno it does not already own. Celgene is in a desperate situation, said Brad Loncar, chief executive of Loncar Investments, which runs the Loncar Cancer Immunotherapy ETF.
Killing of Mother-Daughter Team Shakes Polio Eradication Drive in Pakistan
A mother-daughter team - were shot dead in Pakistan on Thursday, the first time in two years that the polio eradication drive has been shaken by assassinations. While tragic, the killings in Baluchistan province will not seriously disrupt Pakistan's eradication drive, said one of its leaders. We are very close to winning the battle, said Aziz Memon, a textile executive who heads Rotary International's local polio vaccination efforts.
New drugs recast $10 billion hemophilia market as Sanofi swoops in
Sanofi is placing a big bet on the $10 billion-a-year hemophilia market at a testing time, as scientific advances overhaul traditional approaches to treating the rare uncontrolled bleeding disorder. The French drugmaker's decision to buy US hemophilia specialist Bioverativ for $11.6 billion exposes it to competition from Roche's new drug Hemlibra and looming threats from gene therapy. Patients with the genetic blood disorder have traditionally depended on receiving factor replacement therapies, sometimes as often as every other day.

Want to stay updated ?


Download our Android app and stay updated with the latest happenings!!!

50K+ people are using this